Thienotriazolodiazepine
Flubrotizolam Legal status
4-bromo-7-(2-fluorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6 ]trideca-2(6),4,7,10,12-pentaene
CAS Number PubChem CID UNII CompTox Dashboard (EPA ) Formula C 15 H 10 Br F N 4 S Molar mass 377.24 g·mol−1 3D model (JSmol )
CC1=NN=C2N1C3=C(C=C(S3)Br)C(=NC2)C4=CC=CC=C4F
InChI=1S/C15H10BrFN4S/c1-8-19-20-13-7-18-14(9-4-2-3-5-11(9)17)10-6-12(16)22-15(10)21(8)13/h2-6H,7H2,1H3
Key:VOZDBDBHBXLWCG-UHFFFAOYSA-N
Flubrotizolam (2-bromo-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine ) is a thienotriazolodiazepine derivative with potent sedative and anxiolytic effects, which has been sold as a designer drug .[ 1] [ 2] [ 3]
^ US 4094984 , Weber KH, Bauer A, Danneburg P, Kuhn FJ, "6-Phenyl-8-bromo-4H-s-triazolo-[3,4C]-thieno-[2,3E]-1,4-diazepines and salts thereof.", issued 13 June 1978, assigned to Boehringer Ingelheim
^ Catalani V, Botha M, Corkery JM, Guirguis A, Vento A, Scherbaum N, Schifano F (July 2021). "The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity" . Pharmaceuticals . 14 (8): 720. doi :10.3390/ph14080720 . PMC 8398354 . PMID 34451817 .
^ Catalani V, Floresta G, Botha M, Corkery JM, Guirguis A, Vento A, et al. (January 2023). "In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines". Chemical Biology & Drug Design . 101 (1): 40–51. doi :10.1111/cbdd.14119 . hdl :2299/25749 . PMID 35838189 . S2CID 250559695 .